(3E,5E)-3,5-Bis(pyridin-3-methylene)-tetrahydrothiopyran-4-one enhances the inhibitory effect of gemcitabine on pancreatic cancer cells

Panpan Wu,Xiao Wang,Yuran Ma,Xuetao Xu,Wenfeng Liu,Zhaojun Sheng,Min Chen,Renping Zhou,Kun Zhang,Susan Goodin,Xi Zheng,Dongli Li
DOI: https://doi.org/10.1016/j.bioorg.2020.104022
IF: 5.307
2020-08-01
Bioorganic Chemistry
Abstract:<p>Gemcitabine (<em>GEM</em>) is a commonly used treatment for advanced pancreatic cancer. However, chemoresistance and toxic side effect limits its clinical success. In an earlier study, our laboratory found that the curcumin analogue, (3<em>E</em>,5<em>E</em>)-3,5-Bis(pyridin-3-methylene)-tetrahydrothiopyran-4-one (FN2) had strong inhibitory effect on human pancreatic cancer cells. In the present study, we investigated the effects of FN2 in combination with <em>GEM</em> on growth inhibition and apoptosis in human pancreatic cancer Panc-1 cells. The results showed that the combination of FN2 and <em>GEM</em> synergistically inhibited the growth of Panc-1 cells. Panc-1 cells survived the <em>GEM</em> treatment became partially resistant to the drug. Treatment with FN2 in combination with <em>GEM</em> strongly inhibited the growth and stimulated apoptosis in the <em>GEM</em> resistant Panc-1 cells. Mechanistic studies showed that inhibition of cell growth and induction of apoptosis in the <em>GEM</em> resistant Panc-1 cells were associated with decreases in activation of NF-κB and Akt. FN2 in combination with <em>GEM</em> also decreased the level of Bcl-2 and increased the level of Bax. Results of the present study indicate that <em>GEM</em> in combination with FN2 may represent an effective strategy for improving the efficacy of <em>GEM</em> and decreasing the resistance of pancreatic cancer to <em>GEM</em> chemotherapy.</p>
biochemistry & molecular biology,chemistry, organic
What problem does this paper attempt to address?